Drug Profile
Neprapazole
Alternative Names: TY 11345Latest Information Update: 23 May 2000
Price :
$50
*
At a glance
- Originator Toa Eiyo
- Class Antiulcers; Benzimidazoles; Gastric antisecretories; Small molecules
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 23 May 2000 Discontinued-II for Peptic ulcer in Japan (PO)
- 14 Oct 1996 Phase-II clinical trials for Peptic ulcer in Japan (PO)
- 04 Oct 1996 TY 11345 is now called Neprapazole